Snapshot · ASX Health Care · generated 2026-09-28 01:53 UTC

NEU.AX — Neuren Pharmaceuticals Limited

EXPENSIVE (MOS -150.4%) · Quality 47/100

NEU.AX - Neuren Pharmaceuticals Limited
Data generated 2026-09-28 01:53 UTC (nightly scan, universe: ASX Health Care).
Price: 20.08 AUD
Intrinsic value: 8.02 AUD
Margin of safety: -150.4%
Implied growth (reverse DCF): +14.0% (model assumes +0.0%)
Valuation: EXPENSIVE
Value Score: 8.6
Quality: 47/100
Moat score: 40.5 (erosion: none)
EXPENSIVE (MOS -150.4%) - Quality 47/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/NEU.AX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

20.08

Intrinsic value

8.02

Margin of safety

-150.4%

Implied growth (reverse DCF)

+14.0%

model assumes +0.0%

Value Score

8.6

Quality

Psychology

14.4

Discovery

3.9

price/volume attention only

Moat score

40.5

erosion: none

Value Score: bottom 8% of ASX Health Care · Quality: bottom 18%

Dividend: 0.15/share (TTM) · yield 0.8% · payout 100%

Open the interactive Deep Dive for NEU.AX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NEU.AX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NEU.AX undervalued?

As of 2026-09-28, NEU.AX trades at 20.08 against a computed intrinsic value of 8.02 (-150.4% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Neuren Pharmaceuticals Limited's Value Score?

Neuren Pharmaceuticals Limited's Value Score is 8.6 as of 2026-09-28 - it combines value, quality, crowd psychology and market attention into one number.

Does NEU.AX pay a dividend?

Yes - NEU.AX's trailing twelve-month dividend is 0.15/share, a yield of 0.8% at the current price (as of 2026-09-28).